RxDoctor Payments Data

James Carroll, MD

Emergency Medicine · Springfield, MANPI 1962439695

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $204 of the $275 with a category attached, or 74.0%. E.r. Squibb & Sons, L.L.C. accounts for 74.0% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $204, more than ten times the $15 reported in 2019. Among emergency medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$275in general payments, 2019–2025

Across 5 payments — averaging $55.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$204
  • Gilead$32
  • CSL Behring$25
  • AbbVie$15
$327,083in research payments, 2019–2025

Across 38 payments — averaging $8607.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Indivior Inc.$327K
  • Eli Lilly$224

What the payments were for

  • Travel & lodging$20474%
  • Food & beverage$7226%

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.1$204
Gilead2$32
CSL Behring1$25
AbbVie1$15

How this compares

$275 in reported general payments places this provider in the 90th percentile of 1,429 emergency medicine providers in Massachusetts.

See all emergency medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$44,845
Medicare patients
172
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SublocadeBuprenorphine35$72,836
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl179$12,613
SuboxoneBuprenorphine Hcl/Naloxone Hcl32$11,885
Buprenorphine Hcl13$227

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →